Atlas Trials

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Clinical trial NCT01717170 · UNKNOWN

Trial details

NCT number
NCT01717170
Sponsor
University of Nebraska
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Intermediate UveitisPosterior UveitisPan-uveitis
Start date
2013-03-01
Primary completion
2017-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.